2020DefinitionsOpen access

Institutional Review Board Independent Ethics Committee Clinical Trial Status Report

National Cancer Institute

Open full text 0 citations

Abstract

Records sent to an Institutional Review Board (IRB)/Independent Ethics Committee (IEC) of all findings that may adversely affect the safety of a subject, impact the conduct of a clinical trial, alter the IRB/IEC's willingness to continue the trial.

Open-access reader

About this research paper

What this paper is about

Records sent to an Institutional Review Board (IRB)/Independent Ethics Committee (IEC) of all findings that may adversely affect the safety of a subject, impact the conduct of a clinical trial, alter the IRB/IEC's willingness to continue the trial.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Records sent to an Institutional Review Board (IRB)/Independent Ethics Committee (IEC) of all findings that may adversely affect the safety of a subject, impact the conduct of a clinical trial, alter the IRB/IEC's willingness to continue the trial.

Key concepts: Institutional review board, Ethics committee, Clinical trial, Affect (linguistics), Subject (documents), Medicine, Political science, Engineering ethics

Related papers

Back to paper searchBrowse research topicsOriginal source
Institutional Review Board Independent Ethics Committee Clinical Trial Status Report — Research Paper | ScholarLens